» Articles » PMID: 17305336

Role of Zinc Content on the Catalytic Efficiency of B1 Metallo Beta-lactamases

Overview
Journal J Am Chem Soc
Specialty Chemistry
Date 2007 Feb 20
PMID 17305336
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Metallo beta-lactamases (MbetaL) are enzymes naturally evolved by bacterial strains under the evolutionary pressure of beta-lactam antibiotic clinical use. They have a broad substrate spectrum and are resistant to all the clinically useful inhibitors, representing a potential risk of infection if massively disseminated. The MbetaL scaffold is designed to accommodate one or two zinc ions able to activate a nucleophilic hydroxide for the hydrolysis of the beta-lactam ring. The role of zinc content on the binding and reactive mechanism of action has been the subject of debate and still remains an open issue despite the large amount of data acquired. We report herein a study of the reaction pathway for binuclear CcrA from Bacteroides fragilis using density functional theory based quantum mechanics-molecular mechanics dynamical modeling. CcrA is the prototypical binuclear enzyme belonging to the B1 MbetaL family, which includes several harmful chromosomally encoded and transferable enzymes. The involvement of a second zinc ion in the catalytic mechanism lowers the energetic barrier for beta-lactam hydrolysis, preserving the essential binding features found in mononuclear B1 enzymes (BcII from Bacillus cereus) while providing a more efficient single-step mechanism. Overall, this study suggests that uptake of a second equivalent zinc ion is evolutionary favored.

Citing Articles

Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.

Bahr G, Gonzalez L, Vila A Chem Rev. 2021; 121(13):7957-8094.

PMID: 34129337 PMC: 9062786. DOI: 10.1021/acs.chemrev.1c00138.


The Case for Enzymatic Competitive Metal Affinity Methods.

Reilley D, Hennefarth M, Alexandrova A ACS Catal. 2021; 10(3):2298-2307.

PMID: 34012720 PMC: 8130888. DOI: 10.1021/acscatal.9b04831.


Frontiers of metal-coordinating drug design.

Palermo G, Spinello A, Saha A, Magistrato A Expert Opin Drug Discov. 2021; 16(5):497-511.

PMID: 33874825 PMC: 8058448. DOI: 10.1080/17460441.2021.1851188.


Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.

Palacios A, Rossi M, Mahler G, Vila A Biomolecules. 2020; 10(6).

PMID: 32503337 PMC: 7356002. DOI: 10.3390/biom10060854.


Structural and biochemical characterization of the environmental MBLs MYO-1, ECV-1 and SHD-1.

Frohlich C, Sorum V, Huber S, Samuelsen O, Berglund F, Kristiansson E J Antimicrob Chemother. 2020; 75(9):2554-2563.

PMID: 32464640 PMC: 7443720. DOI: 10.1093/jac/dkaa175.


References
1.
Garrity J, Carenbauer A, Herron L, Crowder M . Metal binding Asp-120 in metallo-beta-lactamase L1 from Stenotrophomonas maltophilia plays a crucial role in catalysis. J Biol Chem. 2003; 279(2):920-7. DOI: 10.1074/jbc.M309852200. View

2.
Spencer J, Read J, Sessions R, Howell S, Blackburn G, Gamblin S . Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography. J Am Chem Soc. 2005; 127(41):14439-44. DOI: 10.1021/ja0536062. View

3.
Moali C, Anne C, Lamotte-Brasseur J, Groslambert S, Devreese B, Van Beeumen J . Analysis of the importance of the metallo-beta-lactamase active site loop in substrate binding and catalysis. Chem Biol. 2003; 10(4):319-29. DOI: 10.1016/s1074-5521(03)00070-x. View

4.
Hernandez Valladares M, Felici A, Weber G, Adolph H, Zeppezauer M, Rossolini G . Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability. Biochemistry. 1997; 36(38):11534-41. DOI: 10.1021/bi971056h. View

5.
Orellano E, Girardini J, Cricco J, Ceccarelli E, Vila A . Spectroscopic characterization of a binuclear metal site in Bacillus cereus beta-lactamase II. Biochemistry. 1998; 37(28):10173-80. DOI: 10.1021/bi980309j. View